Papers matching “pathological complete response” 175
Not finding it? Sign in to also search OpenAlex live.
-
Data from Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial
Peter Andreas Fasching, Christopher W. Szeto, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Patricia Spilman, +18 more
0citations -
Data from Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial
Peter Andreas Fasching, Christopher W. Szeto, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Patricia Spilman, +18 more
0citations -
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer2021 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Bruno Valentin Sinn, Sibylle Loibl, Claus Alexander Hanusch, Dirk-Michael Zahm, Hans‐Peter Sinn, Michael Untch, +16 more
46citations -
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials2024 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Paul Jank, Thomas Karn, Marion van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, +18 more
13citations -
Value of breast and axillary tumour-infiltrating lymphocytes for response to neoadjuvant chemo-(immuno)therapy in clinically node-positive breast cancer2026 Clinical Breast Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Melissa Lenaerts, Loes F. S. Kooreman, Florien J G van Amstel, P. J. van Diest, Sander M. J. van Kuijk, Ernest J. T. Luiten, +28 more
0citations -
Abstract PD5-08: Tumor immune-cell activity assessed by RNAseq is an independent predictor of therapy response and prognosis after neoadjuvant chemotherapy in HER2 negative breast cancer patients - An analysis of the GeparSepto trial2020 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies cited by 1 patent
Peter Andreas Fasching, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Christopher W. Szeto, Jan Budczies, +17 more
1citations -
Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer2021 Breast Cancer Research and Treatment article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Emma Josephine Groen, Marieke E. M. van der Noordaa, Michael Schaapveld, Gabe S. Sonke, Ritse M. Mann, Mette S. van Ramshorst, +4 more
17citations -
Abstract PS4-08-07: Predicting response and survival after neoadjuvant systemic treatment with on-treatment biopsies2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
C. Denkert, A. Schneeweiss, V Schaser, Michael Untch, M. Van Mackelenbergh, J.-U. Blohmer, +17 more
0citations -
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial2020 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Thomas Karn, Tobias Meißner, Karsten Ernst Weber, Christine Solbach, Carsten Denkert, Knut Engels, +19 more
16citations -
Prediction of axillary response in 5,262 patients with node-positive breast cancer treated with neoadjuvant chemotherapy: Results from the prospective multicenter AXSANA/EUBREAST-03/AGO-B-053 study.2026 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Maggie Banys‐Paluchowski, Thorsten Kühn, Steffi Hartmann, Jana de Boniface, Nina Caroline Ditsch, Oreste Gentilini, +15 more
0citations -
The impact of emotional distress on pathologic response and survival after neoadjuvant combination immune checkpoint blockade (ICB) in high-risk stage III melanoma.2023 Journal of Clinical Oncology conference-abstract Medicine Cancer Immunotherapy and Biomarkers Open access
Irene L. M. Reijers, Itske Fraterman, Petros Dimitriadis, Annegien Broeks, Maria Gonzalez, Alexander Maxwell Menzies, +7 more
3citations -
Reconstructing tumor history in breast cancer: signatures of mutational processes and response to neoadjuvant chemotherapy⋆2021 Annals of Oncology article Biochemistry, Genetics and Molecular Biology Cancer Genomics and Diagnostics Open access
Carsten Denkert, Michael Untch, Stephen Charles Benz, Andreas Schneeweiß, Karsten Ernst Weber, Sabine Schmatloch, +22 more
23citations -
Predictive value of [18F]FDG PET/CT and index lymph node response following neoadjuvant pembrolizumab in resectable stage 3 melanoma: real world data from the largest melanoma centres in the Netherlands2025 SSRN Electronic Journal preprint Medicine Cutaneous Melanoma Detection and Management Open access
Antonius W Schurink, Yvonne M. Schrage, Michel W.J.M. Wouters, Winan J. van Houdt, Dirk Jan Grünhagen, Johannes V. van Thienen, +2 more
0citations -
On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer2024 Research Square preprint Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Bruno Valentin Sinn, Katharina Sychra, Michael Untch, Thomas Karn, Marion van Mackelenbergh, Jens Huober, +13 more
0citations -
Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment After Neoadjuvant Checkpoint Inhibitor Therapy in Patients With Stage III Melanoma
Irene L. M. Reijers, Robert V. Rawson, Andrew J. Colebatch, Elisa A. Rozeman, Alex Menzies, Alexander C. J. van Akkooi, +13 more
55citations -
First safety and efficacy results of PRADO: A phase II study of personalized response-driven surgery and adjuvant therapy after neoadjuvant ipilimumab (IPI) and nivolumab (NIVO) in resectable stage III melanoma.2020 Journal of Clinical Oncology conference-abstract Medicine Cutaneous Melanoma Detection and Management
Christian U. Blank, Irene L. M. Reijers, Thomas E. Pennington, Judith M. Versluis, Robyn P.M. Saw, Elisa A. Rozeman, +14 more
62citations -
Ultrasound localization microscopy for improved preselection and monitoring of breast cancer patients undergoing neoadjuvant chemotherapy2025 The Journal of the Acoustical Society of America conference-abstract Engineering Ultrasound and Hyperthermia Applications
Céline Porte, Matthias Kohlen, Thomas Lisson, Stefanie Dencks, Zuzanna Magnuska, S Freifrau von Stillfried, +7 more
0citations -
The Predictive Value of the Tumor‐Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor‐Positive Breast Cancer2026 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Layla Andour, Sophie C. Hagenaars, Anne Florine de Groot, Elly MM Krol-Warmerdam, Judith R. Kroep, Hans Marten Hazelbag, +3 more
1citations -
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy2022 BMC Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Jonas Leichsenring, Valentina A. Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, +14 more
1citations -
Tumor-Infiltrating Lymphocytes and Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer: Insights From the Prospective PAPBI Cohort2025 International Journal of Radiation Oncology*Biology*Physics article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Jetske L B Gunster, Emma Josephine Groen, Roberto Salgado, Corrie A.M. Marijnen, Astrid N. Scholten
3citations